OBJECTIVE - Islet amyloidosis may be one mechanism for pancreatic isle
t beta-cell loss that is associated with the development of NIDDM. How
ever, the question remains whether chronic overstimulation of insulin
and islet amyloid polypeptide (LAPP) secretion in states of insulin re
sistance could lead to formation of islet amyloidosis and hence NIDDM
in some patients. We studied pancreatic islet pathology in congenital
generalized lipodystrophy, a genetic syndrome of extreme insulin resis
tance that may provide some clues. RESEARCH DESIGN AND METHODS - Our p
atient was a 24-year-old African-American woman with congenital genera
lized lipodystrophy. Severe acanthosis nigricans was noted in her sinc
e age 6. At ages 12 and 16, normal and impaired glucose tolerances, re
spectively, were noted on oral glucose tolerance rests but were accomp
anied by extreme fasting and postprandial hyperinsulinemia. Overt diab
etes developed at age 18 and she required similar to 180 U of insulin
daily. Immediately after an accidental death at age 24, an autopsy was
performed. Pancreatic histology was studied in detail using routine m
ethods and immunohistochemical techniques. RESULTS - Some scarring of
the pancreas as a result of previous episodes of acute pancreatitis wa
s observed. Severe amyloidosis was noted in 89% of the islets, sparing
those that were rich in pancreatic polypeptide-secreting cells. Amylo
id deposits stained intensely on immuno-staining with antibodies again
st amylin. Marked paucity of beta-cells was evident. The ratio of beta
- to alpha-cells was reduced to 1:1 (normal ratio similar to 4:1). CON
CLUSIONS - These observations suggest that chronic presence of extreme
insulin resistance may induce premature and severe islet amyloidosis
as well as beta-cell atrophy.